[EN] AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS<br/>[FR] COMPOSÉS D'AZAINDOLE UTILISÉS EN TANT QU'INHIBITEURS D'HISTONE MÉTHYLTRANSFÉRASE
申请人:GLOBAL BLOOD THERAPEUTICS INC
公开号:WO2018226998A1
公开(公告)日:2018-12-13
The present disclosure provides certain angular tricyclic compounds that are histone methyltransferases G9a and/or GLP inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of G9a and/or GLP such as cancers and hemoglobinopathies (e.g., beta-thalassemia and sickle cell disease). Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
申请人:Bristol-Myers Squibb Company
公开号:US20170050964A1
公开(公告)日:2017-02-23
The present application describes lactam-containing compounds and derivatives thereof of Formula I:
P
4
—P-M-M
4
I
or pharmaceutically acceptable salt forms thereof, wherein ring P, if present is a 5-7 membered carbocycle or heterocycle and ring M is a 5-7 membered carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.
Compositions and processes for controlling nematodes are described herein, e.g., nematodes that infest plants or animals. The compounds include oxazoles, oxadiazoles and thiadiazoles.
[EN] COMPOSITIONS AND METHODS FOR IMPROVING AGRONOMIC CHARACTERISTICS OF PLANTS<br/>[FR] COMPOSITIONS ET PROCÉDÉS DESTINÉS À AMÉLIORER DES CARACTÉRISTIQUES AGRONOMIQUES DE PLANTES
申请人:MONSANTO TECHNOLOGY LLC
公开号:WO2016100766A1
公开(公告)日:2016-06-23
Compounds, compositions and methods for improving one or more agronomic characteristics of desired crop plants are described herein. The compounds include oxazoles, oxadiazoles and thiadiazoles.
Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.